markus-spiske-hvsr_cvecvi-unsplash

Genentech and NVIDIA enter AI research collaboration

Betsy Goodfellow | November 22, 2023 | News story | Research and Development AI, Genentech, Pharmacy, research collaboration 

Genentech has announced that it has entered into a multi-year strategic research collaboration with NVIDIA that is intended to pair Genentech’s artificial intelligence (AI) capabilities, biological and molecular datasets and research expertise with NVIDIA’s accelerated computing capabilities and AI in order to speed up drug discovery and development.

The companies are expected to work together to accelerate and optimise Genentech’s proprietary machine learning (ML) algorithms and models on NVIDIA DGX Cloud software. NVIDIA will share its computing expertise with Genentech’s teams to improve their platforms.

It is intended that this collaboration will provide Genentech’s teams with new insights for target and drug discovery as well as answering fundamental questions about human biology and disease. 

Advertisement

Aviv Regev, EVP and head of Genentech Research and Early Development (gRED), commented: “By harnessing the power of AI models and algorithms, with our unique data and experiments, we’re unlocking scientific discoveries with incredible speed and generating insights at an unprecedented scale. Bringing science and technology together has always been a foundation of biomedical breakthroughs at Genentech. We are thrilled to join forces with NVIDIA to further optimise our drug discovery and development to deliver treatments that transform people’s lives.”

Betsy Goodfellow

Related Content

Cellbyte raises $2.75m to fund pharma drug launch platform

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of …

drug-trials

MultiOmic Health and BIO4 Campus sign collaborative Memorandum of Understanding

MultiOmic Health (MOH), an artificial intelligence (AI)-enabled precision medicine biotechnology company and BIO4 Campus (BIO4), …

hospital

Sanome’s AI tool gains certification for early detection of hospital infections

Sanome’s MEMORI, an artificial intelligence (AI) medical device that can predict hospital-acquired infections up to …

The Gateway to Local Adoption Series

Latest content